recognize the symptoms of pancreatitis in this population. However, marrow transplant patients may be predisposed to developing pancreatitis due to the high prevalence of Pancreatitis has been described as an infrequent complication of marrow transplantation. This study investibiliary sludge and sonographic biliary tract abnormalities, 2,3
use of irradiation and cytotoxic drugs in the conditioning gated the prevalence of pancreatitis at autopsy in marrow transplant patients and determined risk factors for regimen, and treatment with medications that have been associated with pancreatitis such as corticosteroids and its development. We reviewed consecutive autopsy reports from 1991 to 1993. Medical records and laboracyclosporine. [4] [5] [6] [7] [8] [9] [10] [11] [12] Infectious etiologies of pancreatitis are also possible because of the profound immunosuppression tory reports were reviewed for analysis of clinical variables. Autopsy findings and clinical variables were corthat develops after transplant. There are reports in marrow transplant patients of disseminated cytomegalovirus, related with the autopsy diagnosis of pancreatitis. Pancreatitis was found in 51 of 184 (28%) patients at adenovirus, and varicella zoster virus infections involving the pancreas and mimicking attacks of idiopathic autopsy. Of those with pancreatitis, 35% had abdominal pain, 10% had measurements of serum pancreatic pancreatitis.
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To estimate the prevalence of pancreatitis at autopsy in enzymes, and 20% had abdominal imaging studies in the week prior to death. By univariable analysis, risk marrow transplant patients, we reviewed the histologic and gross findings from all patients autopsied at our center factors associated with development of pancreatitis included clinical grades 3 and 4 GVHD, GVHD at autobetween January 1991 and December 1993. Clinical, radiologic, and laboratory data were also reviewed to analyze psy, liver GVHD at autopsy, major infection at autopsy, and increasing days of survival. By multivariable analythe frequency of pre-mortem signs and symptoms in patients with pancreatitis. Gallbladder contents were sis, independent risk factors for its development included any GVHD at autopsy, increasing length of obtained at autopsy and analyzed chemically and microscopically for the presence of sludge, as previously survival after transplantation, and major infection at autopsy. We conclude that pancreatitis is a common but described. 17 To determine risk factors for its development, the frequency of clinical and therapeutic parameters in often subclinical complication of marrow transplantation. Its development may be associated with a high patients with pancreatitis was compared to those in patients without pancreatitis. prevalence of biliary sludge and prolonged treatment of GVHD with cyclosporine and prednisone. Keywords: acute pancreatitis; bone marrow transplant; Materials and methods corticosteroids; graft-versus-host disease; hematopoietic stem cell transplantation; malignant disease
Marrow transplant technique
Patients undergoing marrow transplantation received conditioning therapy (chemotherapy with or without total body Although pancreatitis is a relatively common disorder in irradiation) as previously described. 18 Recipients of allohospital-based populations, it has only recently been geneic marrow were treated with prophylactic medications described as a complication of marrow transplantation, to prevent acute graft-versus-host disease, usually combioccurring in 3.5% of children undergoing this procedure at nations of cyclosporine and methotrexate. 19 Patients at risk one institution. 1 The presence of multiple other causes of for herpes virus infection were given prophylactic acyclovir abdominal pain; nausea, and vomiting (such as conditioning or ganciclovir. 20, 21 For patients who developed acute grafttoxicity, infections, liver disease, or graft-versus-host disversus-host disease, prednisone at 1-2 mg/kg/day was the ease (GVHD) of the intestinal tract) may make it difficult to initial therapy. Patients were categorized as being in remission or were excluded from analysis, leaving a final cohort of 184 relapse at time of transplantation. Those with non-maligpatients (47% of total deaths) who had undergone marrow nant disorders or CML in chronic phase were considered transplantation. Recipients of both autologous (n = 31) and to be in remission. For total body irradiation, patients were allogeneic transplants (n = 153) were included in this analycategorized by whether or not any irradiation was given sis. At autopsy, we noted the presence or absence of panand by radiation dose (0 Gy, 13.2 Gy, 13.2 to 14.4 Gy, or creatitis (as defined below), graft-versus-host disease Ͼ14.4 Gy). GVHD was examined in four separate ways -(GVHD), biliary tract abnormalities (gallbladder sludge or presence of any GVHD at autopsy, liver GVHD at autopsy, stones, common bile duct sludge or stones, cholecystitis), intestinal GVHD at autopsy, and overall clinical grade of other liver diseases such as infection or veno-occlusive dis-GVHD (grades 0 to 4). 23 Prophylactic medications for ease, or any major infection at the time of death. Patients GVHD were grouped into the categories of none with GVHD were also subclassified by the organs affected (autologous marrow recipients), any cyclosporine-contain-(skin, liver, or intestine).
ing regimen, or other regimens (generally containing methotrexate or corticosteroids). Liver disease at autopsy included veno-occlusive disease, GVHD, steatosis, cholestDefinition of pancreatitis at autopsy asis, recurrent neoplasm, congestion, or hepatic infection. Mild pancreatitis was defined as interstitial edema, scatUse of selected medications during the patients' course tered peripancreatic fat necrosis, and mild inflammation was also reviewed, including the day relative to transplant on with scattered neutrophilic infiltration. Moderate pancreawhich the medications were started and the total number of titis was defined as moderate inflammation, mild acinar cell days on which the medications were given. Medications ananecrosis, and moderate peripancreatic fat necrosis. Severe lyzed included amphotericin, penicillins, cephalosporins, pancreatitis was defined as presence of hemorrhage, wideaminoglycosides, acyclovir, ganciclovir, omeprazole, trispread parenchymal necrosis, extensive peripancreatic fat methoprim-sulfamethoxazole, fluconazole, corticosteroids, necrosis, or pseudocyst formation. Patients in whom pancyclosporine, and anti-thymocyte globulin (ATG). Daily creatitis was felt to be a cause of death based on pathologic corticosteroid doses greater than or equal to the equivalent review were also noted.
of 50 mg of hydrocortisone were counted in this analysis.
Clinical and laboratory manifestations of pancreatitis
The medical records of patients with pancreatitis were examAnalysis of gallbladder contents ined for reports of abdominal pain in the time periods of 1 to 2 weeks prior to death and the week prior to death, Gallbladder contents were obtained at autopsy by incision respectively. Reports of any abdominal imaging studies and drainage of the gallbladder into a sterile container. (ultrasound, CT X-ray, or magnetic resonance) were also Samples were frozen until analysis could be performed. reviewed for visualization of the pancreas and pancreatic Gallbladder sludge was defined as viscous bile with susabnormalities. Laboratory reports for the years 1991 to 1993 pended particles. Particles larger than 2 mm and which were reviewed for measurements of total serum amylase, could not be crushed digitally were classified as gallstones. pancreatic amylase, or lipase. Measurements were considered abnormal if greater than the upper limit of normal for our laboratory. If these measurements were not made during a patient's course, we assumed that pancreatitis was Statistical methods not suspected clinically. Analysis of measurements in three time periods were made: in the 4 weeks prior, in the 2 weeks
In order to determine which, if any, factors were signifiprior, and in the week prior to death, to determine if pancreacantly associated with the probability of pancreatitis at titis was suspected in the immediate pre-mortem period.
autopsy, logistic regression was used to relate the probability of pancreatitis to various covariables. Factors that were statistically significant or suggestive of being associaAnalysis of risk factors for pancreatitis ted with the finding of pancreatitis at autopsy from univariRisk factors examined included age, gender, underlying disable models were used to build multivariable models. Only ease, disease status (relapse vs remission for malignant variables that were statistically significantly associated with disorders), type of transplant (autologous vs allogeneic), or suggestive of being associated with the probability of whether undergoing first or second transplant, pre-transplant pancreatitis at autopsy were included in the multivariable cytomegalovirus (CMV) serology of patient and donor, presmodels. For the univariable and multivariable models, P ence and dose of total body irradiation (TBI) during convalues are two-sided and are derived from the Wald test. ditioning therapy, engraftment (by trilineage criteria), presNo adjustments for multiple comparisons were made in ence of major infection at autopsy, presence and site of calculating the reported P values. involvement of graft-versus-host disease (GVHD) at autopsy, presence of any liver disease at autopsy, clinical grade
Results
seen, one with pancreatic pseudocysts on both ultrasound and CT, and one with an enlarged pancreas, peripancreatic edema and possible pseudocyst with hemorrhage by CT. In Prevalence of pancreatitis at autopsy the week prior to death, 10 of the 51 (19.6%) patients with Fifty-one of 184 (28%) patients whose pancreas was evalupancreatitis had abdominal imaging studies, all by ultraable at autopsy had histologic evidence of pancreatitis. It sound. One study did not image the pancreas adequately for was classified as severe in 22, moderate in four, and mild analysis. Only one of nine evaluable patients had an abnorin 25 patients. Pancreatic infections were noted in five mal imaging study in this time period, showing a mass in patients on tissue staining (two with bacteria, two with the head of the pancreas. All three patients with pancreatic cytomegalovirus, one with aspergillus), but whether infecabnormalities on imaging had severe pancreatitis. However, tion was the sole etiology of pancreatitis in these cases 15 patients with severe pancreatitis did not have abnormalicould not be determined. Pseudocyst formation was not ties on imaging studies. documented in any patient at autopsy.
Pancreatitis as a cause of death Clinical features of pancreatitis
Pancreatitis was felt to be a cause of death in five patients, Symptoms: Fifteen of 51 (29.4%) patients with autopsy-proall of whom had histologically severe pancreatitis. Pancreaven pancreatitis had abdominal pain documented in the time titis was diagnosed or suspected ante-mortem in these period 1 to 2 weeks prior to death. In the week prior to patients, as serum amylase or lipase measurements within death, 18 of 51 (35.3%) patients had complained of pain. A 2 weeks of death were abnormal in all cases. Imaging studhigher proportion with moderate or severe pancreatitis than ies were also obtained in all, and were abnormal in three with mild pancreatitis had complained of abdominal pain.
patients. Pseudocysts were documented by CT in two patients, and a possible pancreatic mass was seen by Laboratory measurements: Of the 51 patients with pancreaultrasound in one patient. titis at autopsy, only 15 had at least one measurement of serum total amylase, pancreatic amylase, or lipase in the 4 weeks prior to death; only 11 had abnormal values (Table 1) .
Pancreatitis in autologous marrow recipients Of 133 patients without evidence of pancreatitis at autopsy, Thirty-one of the 184 patients included in this study had 51 had at least one measurement of amylase or lipase in the received an autologous marrow transplant. Of these 4 weeks prior to death; 13 had abnormal values (Table 1) .
patients, seven had breast cancer, 15 had multiple myeloma, A higher proportion of patients with severe pancreatitis than and nine had non-Hodgkin's lymphoma as their underlying with mild or moderate pancreatitis had these measurements diagnosis. Pancreatitis developed in six of these patients, done (data not shown). All patients with severe pancreatitis and was classified as severe histologically in two, moderate had abnormal values. No patients with mild pancreatitis had in two, and mild in two patients. Pancreatitis was not felt values greater than twice the upper limit of normal.
to be the primary cause of death in any of these patients. Imaging studies: In the time period 1 to 2 weeks prior to death, 24 of the 51 (47.0%) patients with pancreatitis had Risk factor analysis abdominal imaging studies, 13 by ultrasound, seven by CT, and four by both ultrasound and CT. Of these studies, 11
No pre-transplant demographic features predicted the development of pancreatitis (Table 2) . No apparent differdid not image the pancreas adequately for analysis. Only two of 13 evaluable patients had abnormalities of the pancreas ence in underlying diseases was found between patients The doses Marrow transplant patients have many potential factors that predispose them to pancreatitis, including a high prevalence required for these changes to develop far exceed the dose of TBI used in marrow transplantation. However, multidrug of biliary sludge and treatment with medications such as corticosteroids that are associated with development of panchemotherapy regimens may cause pancreatitis and the concomitant use of TBI and cytoreductive drugs may lower the creatitis. [4] [5] [6] In this series, we found an unexpectedly high prevalence of pancreatitis at autopsy. This prevalence may threshold for TBI-related damage. The data, however, do not show a relation of pancreatitis to the conditioning regimen. be higher than that found in the general population of patients following marrow transplant. In mild cases, panFour cases of presumed pancreatic GVHD have been described in the literature. 28 Findings included epithelial cell creatitis was often subclinical, as shown by the relative infrequency of abdominal pain and laboratory or imaging atypia and a mild lymphocytic infiltrate in the exocrine ductal system. Histologic changes in both these instances are distinct studies. Severe cases more frequently had abdominal pain, abnormal laboratory values, or abnormal imaging tests. The from those of acute pancreatitis, 29 and no cases of acute pancreatitis were found in either the series of pancreatic GVHD major risk factor for pancreatitis was severe acute GVHD.
Although severe GVHD was identified as a statistically or radiation-induced pancreatitis. Thus, the histologic changes seen in the current autopsy cohort cannot be explained by significant risk factor for pancreatitis in this series, it may be the treatment of GVHD that predisposes patients to pancreatoxic effects of the conditioning regimen or by GVHD itself. However, we cannot rule out the possibility that more subtle titis, rather than GVHD per se. For example, high-dose corticosteroids, often used to treat severe GVHD, may have immunologic alterations occur, causing subclinical pancreatic injury and predisposing to development of acute pancreatitis. contributed to the development of pancreatitis. Pancreatitis patients had a longer mean survival time, suggesting that proAnother possible confounding factor is the occurrence of 'agonal' pancreatitis, occurring in the immediate pre-mortem longed, high-dose immunosuppressive therapy may be required to induce pancreatic toxicity. In fact, one study has period, which could in part explain the high proportion of clinically unsuspected pancreatitis. Others have reported a shown high levels of cyclosporine can be found in the pancreas, adipose tissue, and liver after varying lengths of therhigh incidence of undiagnosed pancreatitis in autopsy series. 30, 31 However, this cannot easily be distinguished from apy. 24 Other studies have found that cyclosporine may induce or worsen acute pancreatitis. 10, 11 In our study, however, non-'agonal' acute pancreatitis on histologic grounds. Gallbladder sludge was seen in all patients, with and neither cyclosporine nor corticosteroids were found to be statistically significant risk factors for development of pancreawithout pancreatitis, at autopsy. Gallbladder sludge in the post-marrow transplant setting has been shown to be primtitis. Widespread use of these medications in patients with and without pancreatitis may not allow their identification as arily composed of calcium bilirubinate. 17 Sludge of this composition is often a result of gallbladder stasis, which risk factors in statistical analysis, and this does not completely exclude the possibility that their use in some way predisposes frequently occurs in the post-transplant setting. 2, 3 In patients after solid organ transplant, pancreatitis has not to the development of pancreatitis. However, the longer mean survival time in patients with pancreatitis could simply imply been a significant complication. One series of patients after renal transplantation noted development of clinical acute that such patients have a longer time period in which they could develop this complication.
pancreatitis in six of 228 (2.6%) who were also receiving cyclosporine and prednisone for immunosuppression.
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The prolonged use of immunosuppressive therapy also enables development of major infection, which may conSteed et al 32 described three out of 143 patients who died of pancreatitis after cardiac transplantation. The incidence found the association of pancreatitis and infection. Although major infection was seen in 75% of cases, pancreof biliary sludge was not given in either report. In the nontransplant population, biliary sludge has been identified as atic infection was seen in only 10% of those with pancreatitis. It is not clear whether infection was the primary cause an etiology in 74% of patients with previously classified 'idiopathic' pancreatitis. 33 The presence of biliary sludge of pancreatitis in these cases. Another finding which remains unexplained is the increased risk of pancreatitis in could be a factor in the development of acute pancreatitis in the marrow transplant population as well, but our data patients undergoing autologous marrow transplantation, who are not at risk for GVHD. As these patients do not shows that all patients had gallbladder sludge at autopsy, irrespective of whether pancreatitis was present. receive prolonged immunosuppression, this cannot be implicated as a risk factor. We also could not explain this
The contribution of pancreatitis to the patients' overall course is difficult to determine in an autopsy study. Pancreafinding by differences in other variables such as conditioning regimens that might make recipients of autologous titis that is mild and subclinical may have few clinical consequences in patients who are severely ill from other congrafts different from recipients of allogeneic transplants.
The histopathology of the pancreas in patients after bone ditions. However, some patients in this study had severe pancreatitis histologically. It is well known that severe panmarrow transplantation has been described. 25 After high-dose chemotherapy, squamous metaplasia of the pancreatic ducts creatitis can lead to systemic complications, including respiratory distress, renal dysfunction, and multiorgan failure. and dilatation of the pancreatic acini with oncocytic changes (eosinophilic cytoplasm and pyknotic nuclei) are seen most Thus, unsuspected severe pancreatitis may have contributed substantially to the terminal course in some of these patients frequently histologically. Both squamous metaplasia and oncocytic changes were attributed to high-dose chemoby causing or exacerbating multiorgan dysfunction. If patients with acute GVHD on prednisone therapy have a therapy, as they were sometimes seen in patients receiving These therapies, however, will be of limited use in patients 
